Amanote Research
Register
Sign In
394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34729-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Cytotoxic Function of Chimeric Antigen Receptor (CAR) T Cells Redirected by Anti-Muci Nanobody
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Chimeric Antigen Receptor (CAR)-redirected T Cells: Is There a Place for Them in Infectious Diseases?
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Prospects to Improve Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
Immunotherapy
Oncology
Allergy
Immunology
Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors
OncoImmunology
Oncology
Allergy
Immunology
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
Gastroenterology
Hepatology
Gastroenterology
Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology